SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Ensysce Q3 net loss widens on in-process R&D charge

Ensysce Q3 net loss widens on in-process R&D charge Overview US biotech's Q3 net loss widened sharpl

ASMBENSCPRMERCKT

Related stories